Tag: COVID-19
India’s cumulative COVID-19 vaccination coverage exceeds 150.61 Crore
This major milestone has been achieved through 1,60,89,073 sessions
Pandemic offers opportunities to scale up interventions for the mental health...
It is time to prioritize the mental and physical wellbeing of those who every day are facing the worst of the pandemic on the frontlines
IIT Mandi researchers plot Covid-19, past pandemics across seasons
According to the study, a robust emergency plan to mitigate the spread of the next pandemic needs to be carefully planned. Knowledge of regions on the trajectory of a pandemic will help better manage a future outbreak.
Covid-19 Third Wave: Doctor consultations up by 54% in a day,...
This is the highest single-day increase in doctor consultations in 120 days, since the decline of the deadly second wave
New study by BHU scientists raises prospect of Zika virus therapy
A team of researchers has found that the virus interacts with a set of cells called microglial cells, which protect the brain from infections and that a protein in the virus called ZIKV-NS1 plays an important role in its replication and immune evasion
67.2% of the fake news in 2021 was health related: Study
Though technology advancements and social media create opportunities to keep people safe, informed and connected, these at the same time also enable and amplify the current INFODEMIC that continues to undermine the global response to control the pandemic
First-ever study in India claims Covid-19 vaccine cocktails are safe
Mix and match of different vaccines is safe and elicits robust antibody response, revealed the study conducted by AIG Hospitals
The first pilot study from India analyzing COVAXIN – COVISHEILD mixed doses
Apollo Hospitals joins the massive vaccination drive for 15-18 year age...
Registration of children in the eligible age group and categories and/or booking of vaccination time-slots in the Apollo 24/7 app has now begun
India hasn’t missed any Covid-19 vaccination target, clarifies govt
As per the data by union health ministry, 90% of the eligible population has been administered the first dose of the vaccine and the coverage is at 65% for the second dose
COVAXIN for children: Study demonstrates robust safety & immunogenicity in 2-18...
Whole-Virion inactivated SARS-CoV-2 Vaccine (BBV152) has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Neutralizing antibodies in children on an average 1.7 times higher than in adults......................